Results 291 to 300 of about 2,694,235 (387)

Immunometabolism at the interface between macrophages and pathogens

open access: yesNature reviews. Immunology, 2019
D. Russell, Lu Huang, B. VanderVen
semanticscholar   +1 more source

Upconversion Nanoparticles Embedded Photonic Contact Lens for Transepithelial Corneal Crosslinking Using Hyaluronate – Riboflavin Conjugate

open access: yesAdvanced Functional Materials, EarlyView.
A minimally invasive, transepithelial corneal cross‐linking (TE‐CXL) approach is presented using upconversion nanoparticles (UCNPs)‐loaded contact lenses (UCLs), after topical delivery of hyaluronate–riboflavin conjugates. The NIR‐to‐UV/blue light conversion by UCNPs in a UCL can activate riboflavin for TE‐CXL, resulting in the biomechanical strength ...
Gibum Lee   +8 more
wiley   +1 more source

Flexible nitrogen utilisation by the metabolic generalist pathogen Mycobacterium tuberculosis

open access: green, 2019
Aleksandra Agapova   +6 more
openalex   +1 more source

Uncommon pathogens (rare pathogens)

open access: yesCirugía Cardiovascular
García-Álvarez, Lara [0000-0002-6518-9698]   +2 more
openaire   +3 more sources

Electrosynthesis of Bioactive Chemicals, From Ions to Pharmaceuticals

open access: yesAdvanced Functional Materials, EarlyView.
This review discusses recent advances in electrosynthesis for biomedical and pharmaceutical applications. It covers key electrochemical materials enabling precise delivery of ions and small molecules for cellular modulation and disease treatment, alongside catalytic systems for pharmaceutical synthesis.
Gwangbin Lee   +4 more
wiley   +1 more source

Host–pathogen interactions

open access: yesCurrent Opinion in Immunology, 2006
Kaufmann, S., Walker, B.
openaire   +3 more sources

Generating Cell Surface Nucleated Hydrogels with an Artificial Membrane‐Binding Transglutaminase

open access: yesAdvanced Functional Materials, EarlyView.
Cell‐based therapies require advanced strategies to enhance cell delivery and bioactivity. Cell membrane engineering offers an avenue to impart new functions to delivered cells to boost their viability and function. Here, an artificial membrane‐binding transglutaminase is generated and biophysically characterized.
Rosalia Cuahtecontzi Delint   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy